However, it can also be linked to underlying inflammation, poor biomechanics, or systemic factors that reduce tissue recovery
Traditional obesity intervention strategies (e.g., dietary control, exercise, conventional weightloss drugs) are often limited by slow onset, obvious side effects, and high rebound rates, and can hardly fundamentally reverse the abnormal metabolic phenotype of adipose tissue
However, as the science surrounding aging and metabolism continues to evolve, clinicians are discovering ways to amplify and extend those benefits
Think of it as hitting the reset button on the worst physical symptoms while giving your body a boost to handle the rest of the recovery process more efficiently
For GLP-1 and dual agonist medications like Zepbound, the theoretical concern centers on their effects on gastric emptying and gastrointestinal function